SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083) (SNOA) — Mar 7, 2011

Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)
Date: March 7, 2011 · CIK: 0001367083 · Accession: 0000000000-11-014270

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-171411

Date
March 7, 2011
Author
Amanda Ravitz Assistant Director
Form
UPLOAD
Company
Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)

Letter

March 7, 2011 Hojabr Alimi President and Chief Executive Officer Oculus Innovative Sciences, Inc. 1129 N. McDowell Blvd. Petaluma, California 94954 Re: Oculus Innovative Sciences, Inc. Registration Statement on Form S-3 Amended February 18, 2011 File No. 333-171411

Dear Mr. Alimi:

We have limited our review of your registra tion statement to those issues we have addressed in our comment. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. After reviewing the information you provide in response to this comment, we may have additional comments.

1. We note your response to prior comment 1. Please note that you will need to resolve any comments on your pending applications for c onfidential treatment prior to requesting acceleration of the effective date of this regi stration statement. Please see Section III.B.2 of Staff Legal Bulletin No. 1. We urge all persons who are responsible for th e accuracy and adequacy of the disclosure in the filing to be certain that the filing incl udes the information the Securities Act of 1933 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disc losure, they are responsible for the accuracy and adequacy of the disclosures they have made. Notwithstanding our comment, in the event you request acceleration of the effective date of the pending registration statement please pr ovide a written statement from the company acknowledging that:

• should the Commission or the staff, acting purs uant to delegated authority, declare the filing effective, it does not foreclose the Co mmission from taking any action with respect to the filing;

Hojabr Alimi Oculus Innovative Sciences, Inc. March 7, 2011 Page 2

• the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

• the company may not assert staff comments a nd the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Please refer to Rules 460 and 461 regarding re quests for acceleration. We will consider a written request for acceleration of the effective date of the regi stration statement as confirmation of the fact that those reques ting acceleration are aware of thei r respective responsibilities under the Securities Act of 1933 and the Securities Excha nge Act of 1934 as they relate to the proposed public offering of the securities specified in th e above registration stat ement. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. You may contact Aslynn Hogue at (202) 551-3841 or Jay Mu mford, Senior Attorney, at (202) 551-3637 with any questions.

Sincerely,
Amanda Ravitz Assistant Director
cc (by facsimile): Amy Trombly, Esq. –– Trombly Business Law, PC

Show Raw Text
March 7, 2011
 Hojabr Alimi President and Chief Executive Officer Oculus Innovative Sciences, Inc. 1129 N. McDowell Blvd. Petaluma, California 94954
Re: Oculus Innovative Sciences, Inc.
Registration Statement on Form S-3 Amended February 18, 2011
  File No. 333-171411

Dear Mr. Alimi:

We have limited our review of your registra tion statement to those issues we have
addressed in our comment.  In some of our comments, we may ask you to provide us with
information so we may better understand your disclosure.
 After reviewing the information you provide in  response to this comment, we may have
additional comments.

1. We note your response to prior comment 1.  Please note that you will need to resolve any
comments on your pending applications for c onfidential treatment prior to requesting
acceleration of the effective date of this regi stration statement.  Please see Section III.B.2
of Staff Legal Bulletin No. 1.  We urge all persons who are responsible for th e accuracy and adequacy of the disclosure
in the filing to be certain that the filing incl udes the information the Securities Act of 1933 and
all applicable Securities Act rules require.  Since the company and its management are in
possession of all facts relating to a company’s disc losure, they are responsible for the accuracy
and adequacy of the disclosures they have made.
Notwithstanding our comment, in the event you request acceleration of the effective date
of the pending registration statement please pr ovide a written statement from the company
acknowledging that:

• should the Commission or the staff, acting purs uant to delegated authority, declare the
filing effective, it does not foreclose the Co mmission from taking any action with respect
to the filing;

Hojabr Alimi
Oculus Innovative Sciences, Inc. March 7, 2011 Page 2

• the action of the Commission or the staff, acting pursuant to delegated authority, in
declaring the filing effective, does not relieve the company from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and

• the company may not assert staff comments a nd the declaration of effectiveness as a
defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.  Please refer to Rules 460 and 461 regarding re quests for acceleration.  We will consider a
written request for acceleration of  the effective date of the regi stration statement as confirmation
of the fact that those reques ting acceleration are aware of thei r respective responsibilities under
the Securities Act of 1933 and the Securities Excha nge Act of 1934 as they relate to the proposed
public offering of the securities specified in th e above registration stat ement.  Please allow
adequate time for us to review any amendment prior to the requested effective date of the
registration statement.
 You may contact Aslynn Hogue  at (202) 551-3841 or Jay Mu mford, Senior Attorney, at
(202) 551-3637 with any questions.

Sincerely,

Amanda Ravitz Assistant Director
 cc (by facsimile):   Amy Trombly, Esq. –– Trombly Business Law, PC